Will Stanford's cancer cell self-destruction method enter human trials by end of 2025? | Binary | | | 2 months ago | |
Will FDA grant breakthrough therapy designation to Stanford's cancer method by mid-2026? | Binary | | | 2 months ago | |
Follow-up study confirms GLUT4 deletion increases neurogenesis by Oct 2025? | Binary | | | 3 months ago | |
Human trials on GLUT4 targeting for neurogenesis start by end of 2025? | Binary | | | 3 months ago | |
Increased research funding for glucose metabolism in neural stem cells by Oct 2025? | Binary | | | 3 months ago | |
First collaboration announcement on GLUT4-related research by Oct 2025? | Categorical | | | 3 months ago | |
Will a peer-reviewed study confirm efficacy of Stanford's protein-gluing technique by November 2025? | Binary | | | 2 months ago | |
Which cancer type will Stanford's treatment target first in human trials by end of 2025? | Categorical | | | 2 months ago | |
Which major pharma company will partner with Stanford for cancer treatment by November 2025? | Categorical | | | 2 months ago | |
Where will Stanford's cancer treatment method be approved first by end of 2026? | Categorical | | | 2 months ago | |
Journal publishing follow-up study on GLUT4 deletion effects by Oct 2025? | Categorical | | | 3 months ago | |
First regulatory review of human trials targeting GLUT4 by Oct 2025? | Categorical | | | 3 months ago | |
